Rivaroxaban After TAVR
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Controlled Trial of Rivaroxaban After Transcatheter Aortic-Valve Replacement
N. Engl. J. Med 2019 Nov 16;[EPub Ahead of Print], GD Dangas, JGP Tijssen, J Wöhrle, L Søndergaard, M Gilard, H Möllmann, RR Makkar, HC Herrmann, G Giustino, S Baldus, O De Backer, AHC Guimarães, L Gullestad, A Kini, D von Lewinski, M Mack, R Moreno, U Schäfer, J Seeger, D Tchétché, K Thomitzek, M Valgimigli, P Vranckx, RC Welsh, P Wildgoose, AA Volkl, A Zazula, RGM van Amsterdam, R Mehran, S WindeckerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.